Class 6- Vaccine Preventable Diseases- Measles, GIS, & R0 Flashcards
First documented account of vaccination
1000AD A Buddhist nun described how smallpox scabs were dried, ground, and blown into the nostrils of susceptible persons
Edward Jenner
In the late 1700s Noted that milkmaids rarely became infected with smallpox-and postulated that contact with cowpox puss protected them 1796 inoculated James Phipps, the son of his gardener, with cowpox. Scrapped pus from a cowpox blister
Inoculation vs Vaccination
Inoculation: Administration of pathogen to induce infection and immunity.
- Historical method for the prevention of smallpox by deliberate introduction into the skin of material from smallpox pustules
- Brought on less-severe symptoms
- 2% mortality in healthy individuals
- Valley forge inoculation- revolutionary war
Vaccination: Administration of antigenic material, that stimulates adaptive immunity (antibody production)
Passive Immunization
Refers to the protection conferred by the transfer of animal or human antibody
Route- injection, in utero, breast feeding Is typically short lived
- maternal antibodies protect newborns for up to 6 months
Active Immunization
Refers to protection produced by the host’s own immune system and relies on the host to generate an immune response
- Longer lasting
Types of Vaccines
Live
- Live organism has been attenuated (weakened)
Inactivated (Killed) vaccine
- Organism is killed by heat, chemicals or radiation
Recombinant
- Created through genetic manipulation of organisms genomic material
- Can be live or inactivated
Vaccines that minimize consequences of infection
Where as some vaccines are imagined as being able to prevent infection, many others prevent or minimize the consequences of infection
- Examples:
- Inactivated polio does not prevent wild-type poliovius from multiplying in the intestinal tract
- Immunity prevents the virus from causing cNS damage
- Toxoid vaccine
- Prevent tissue damage from bacterial toxins
- Inactivated polio does not prevent wild-type poliovius from multiplying in the intestinal tract
<!--StartFragment-->
Vaccine development phases<!--EndFragment-->
Licensure of any new vaccine requires that efficacy be demonstrated from preclinical studies
- Investigational new drug filed with the FDA
- Preclinical studies (animal studies)
- Phase 1: Dose Finding and Safety (small number of volunteers 5-10 people)
- Phase 2: Safety and Immunogenicity trials (post-vaccination serology)
- Phase 3: Comparative Efficacy trials (RCT)
Takes a long time and can be stopped at any of the phases – expensive
Characteristics of an Ideal Vaccine
- Produces a good immune response, similar to natural infection, in a single dose
- Protects against disease
- Provides protection for years/lifetime
- Minimal adverse effects
- Induced immunity confers protections to multiple strains of organisms
- Easy to administer
- Don’t require special handling (e.g. cold chain)
- Doesn’t interfere with other immune responses or vaccines
- Cheap
Contradiction for Vaccination
- Severe allergy to any vaccine component
- Severe illness
- Immunosuppression
- HIV infection
- Pregnancy
- Encephalopathy
- Recent receipt of blood products
List of available vaccines
- HPV
- HBV (hepatitus B)
- TDAP (Tetanus, Diphtheria, Pertussis)
- HIB (Haemophilus Influenzae Type b)
- HAV (hepatitus A)
- MMR
<!--StartFragment-->
Childhood Vaccines in the US<!--EndFragment-->
As of 2009:
- Prevent 42,000 deaths a year and as many as 20 million cases
Costs savings
- $13.5 Billion dollars
- Excludes influenza
<!--StartFragment-->
Vaccines and Autism<!--EndFragment-->
Andrew Wakefield
- Published paper on 28 February 1998 linking the MMR vaccine to autism
- Study suggested that gastrointestinal inflammation, brought on by the MMR vaccine is responsible for autism.
- Published in The Lancet
- Included twelve other authors about twelve autistic children
- Resulted in the creation of the VAERS -Vaccine Adverse Event Reporting System
Shoddy science and multiple accusations of fraudulent billing
- Lead to a decrease in vaccination rates and an increase in preventable diseases in the UK and US.
- Since that time, 200,000 reports have shown there is no link
<!--StartFragment-->
R0<!--EndFragment-->
R0 is the reproductive number of an infectious disease
Immunization rates influence R0 rates
- Fewer susceptible individuals = fewer potential cases (concept of herd immunity)
- R0<1 disease is dying out
- R0=1 endemic stable transmission
- R0>1 epidemic transmission
- Herd immunity threshold = 1- (1/r0)
<!--StartFragment-->
Poliovirus<!--EndFragment-->
Reservoir- Humans- most frequently asymptomatic carriers
- No long term carriers of wild-type polio have been detected (2008)
Route- person to person, fecal-oral, contaminated water
- Virus is more detectable in feces than throat swabs
Incubation- 7 to 14 days for paralytic cases
Symptoms- non specific fever, acute flaccid paralysis (1% of cases)
- Maximum extent of paralysis is usually reached in 3-4 days
Communicability- not well defined, virus persist in throat for 1 week and for 3-6 weeks in feces